• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Related Links
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of High Institute of Public Health
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 55 (2025)
Volume Volume 54 (2024)
Volume Volume 53 (2023)
Volume Volume 52 (2022)
Volume Volume 51 (2021)
Volume Volume 50 (2020)
Volume Volume 49 (2019)
Volume Volume 48 (2018)
Volume Volume 47 (2017)
Volume Volume 46 (2016)
Volume Volume 45 (2015)
Volume Volume 44 (2014)
Volume Volume 43 (2013)
Issue Issue 2
Issue Issue 1
Volume Volume 42 (2012)
Volume Volume 41 (2011)
Volume Volume 40 (2010)
Volume Volume 39 (2009)
Volume Volume 38 (2008)
Volume Volume 37 (2007)
Volume Volume 36 (2006)
Volume Volume 35 (2005)
Volume Volume 34 (2004)
Volume Volume 33 (2003)
Volume Volume 32 (2002)
Volume Volume 31 (2001)
Volume Volume 30 (2000)
Volume Volume 29 (1999)
Selim, H., El shazly, S., Salama, M., Abdolmonem, R. (2013). Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy. Journal of High Institute of Public Health, 43(1), 36-48. doi: 10.21608/jhiph.2013.19987
Heba Selim; Soraya El shazly; Mostafa Salama; Reham Abdolmonem. "Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy". Journal of High Institute of Public Health, 43, 1, 2013, 36-48. doi: 10.21608/jhiph.2013.19987
Selim, H., El shazly, S., Salama, M., Abdolmonem, R. (2013). 'Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy', Journal of High Institute of Public Health, 43(1), pp. 36-48. doi: 10.21608/jhiph.2013.19987
Selim, H., El shazly, S., Salama, M., Abdolmonem, R. Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy. Journal of High Institute of Public Health, 2013; 43(1): 36-48. doi: 10.21608/jhiph.2013.19987

Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy

Article 4, Volume 43, Issue 1, April 2013, Page 36-48  XML PDF (78.82 K)
Document Type: Original Article
DOI: 10.21608/jhiph.2013.19987
View on SCiNiTO View on SCiNiTO
Authors
Heba Selim* 1; Soraya El shazly1; Mostafa Salama2; Reham Abdolmonem1
1Microbiology Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt
2Pediatric Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Abstract
Background: Children in remission from acute lymphoblastic leukemia (ALL) have a high prevalence of immune system defects; one of them is the decrease of vaccine-induced antibody seropositivity rates. This antibody deficiency may place children with ALL at risk for the development of vaccine- preventable diseases, even after completion of chemotherapy, and they could function as a reservoir for additional spread of these diseases in the population. The aim of the present study was the assessment of the levels of vaccine- induced antibodies against measles and rubella viruses in ALL children following chemotherapy. Methods: Antibody levels against measles and rubella vaccine viruses were evaluated by ELISA technique in 96 children with ALL after completion of chemotherapy, in addition to 30 healthy children (non cancer controls of matched age and sex). Results: All healthy children were seropositive for measles and rubella antibodies.On the other hand, out of 96 children who received chemotherapy, only 19 (19.8%) were seropositive for measles antibodies, while 70 (72.9%) were seropositive for rubella antibodies. Most of measles seropositive cases (57.9%) had low levels of measles antibodies while among control group most children (56.7%) had high levels of measles antibodies. Similarly among children who received chemotherapy, most of the seropositive cases (45.7%) had low levels of rubella antibodies, while among control group, most of children (36.6%) had high levels of rubella antibodies. Seropositivity rate of measles was found to be related to the age at diagnosis and disease duration, while that of rubella was found to be related to the disease duration only. Conclusion and recommendations: Most of children who have been treated with chemotherapy for ALL had lost measles antibodies and to less extent rubella antibodies. Among seropositive cases, levels of measles and rubella antibodies are low following treatment with chemotherapy compared to levels among normal controls. Therefore, revaccination of children with ALL following completion of chemotherapeutic treatment against measles and rubella is recommended.
Keywords
Acute lymphoblastic leukemia; measles; rubella; vaccine
Statistics
Article View: 197
PDF Download: 553
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.